tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

PROK Stock Latest News

ProKidney’s Prospects: Analyst Maintains $3 Price Target Amid Rilparencel Developments and Financial Stability
RatingsProKidney’s Prospects: Analyst Maintains $3 Price Target Amid Rilparencel Developments and Financial Stability
8d ago
PROK
ProKidney Corp. Reports Increased Losses Amid Ongoing R&D
PremiumCompany Announcements
ProKidney Corp. Reports Increased Losses Amid Ongoing R&D
9d ago
PROK
ProKidney reports Q1 EPS (13c), consensus (15c)
PremiumThe Fly
ProKidney reports Q1 EPS (13c), consensus (15c)
9d ago
PROK
PROK Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
PROK Upcoming Earnings Report: What to Expect?
2M ago
PROK
ProKidney Hold Rating: Balancing Developmental Progress and Financial Stability Amid Uncertainty
PremiumRatings
ProKidney Hold Rating: Balancing Developmental Progress and Financial Stability Amid Uncertainty
2M ago
PROK
ProKidney reports FY24 EPS (62c), consensus (59c)
PremiumThe FlyProKidney reports FY24 EPS (62c), consensus (59c)
2M ago
PROK
ProKidney sees cash runway into mid-2027
Premium
The Fly
ProKidney sees cash runway into mid-2027
2M ago
PROK
ProKidney’s Progress in FDA Approval and Financial Health
Premium
Company Announcements
ProKidney’s Progress in FDA Approval and Financial Health
6M ago
PROK
ProKidney reports Q3 EPS (14c), consensus (15c)
PremiumThe Fly
ProKidney reports Q3 EPS (14c), consensus (15c)
6M ago
PROK
PROK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
PROK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago
PROK
ProKidney initiated with a Neutral at JPMorgan
PremiumThe Fly
ProKidney initiated with a Neutral at JPMorgan
8M ago
PROK
ProKidney initiated with a Buy at Guggenheim
PremiumThe Fly
ProKidney initiated with a Buy at Guggenheim
8M ago
PROK
ProKidney price target lowered to $3 from $4 at BofA
PremiumThe FlyProKidney price target lowered to $3 from $4 at BofA
9M ago
PROK
ProKidney: Investor Update and Phase 3 Program Progress
Premium
Company Announcements
ProKidney: Investor Update and Phase 3 Program Progress
9M ago
8K
PROK
ProKidney to discontinue PROACT 2, focus resources on PROACT 1
Premium
The Fly
ProKidney to discontinue PROACT 2, focus resources on PROACT 1
9M ago
PROK
ProKidney sees cash runway into mid-2026
PremiumThe Fly
ProKidney sees cash runway into mid-2026
10M ago
PROK
ProKidney reports Q2 EPS (16c), consensus (17c)
PremiumThe Fly
ProKidney reports Q2 EPS (16c), consensus (17c)
10M ago
PROK
Short Report: Sirius XM bears pressing bets into stock rally
PremiumThe Fly
Short Report: Sirius XM bears pressing bets into stock rally
11M ago
ALT
KSS
ProKidney 53.72M share Secondary priced at $2.42
PremiumThe Fly
ProKidney 53.72M share Secondary priced at $2.42
11M ago
PROK
ProKidney announces $125M Class A ordinary shares offering
PremiumThe FlyProKidney announces $125M Class A ordinary shares offering
11M ago
PROK
ProKidney price target lowered to $6 from $15 at Jefferies
Premium
The Fly
ProKidney price target lowered to $6 from $15 at Jefferies
12M ago
PROK
ProKidney Progresses in Kidney Disease Treatment Trials and Regulation
Premium
Company Announcements
ProKidney Progresses in Kidney Disease Treatment Trials and Regulation
12M ago
8K
PROK

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >